封面
市场调查报告书
商品编码
1361747

全球伤口护理生物製品市场报告

Global Wound Care Biologics Market Report

出版日期: | 出版商: Value Market Research | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

全球伤口护理生物製品市场需求预计将从 2022 年的 2.63 万美元达到 2030 年近 4.06 万美元的市场规模,2023-2030 年研究期间复合年增长率为 6.4%。

伤口护理生物製剂是用于治疗不癒合的下肢伤口的生物工程产品。伤口生物製剂涵盖了伤口处理的每个阶段。这包括确定伤口类型、明确影响伤口癒合的因素以及应用适当的伤口管理疗法。伤口生物製剂涵盖伤口护理的每个步骤。这需要识别伤口类型,找出影响伤口癒合的因素,并实施适当的伤口管理治疗。一旦评估了伤口并检查了所有要求,治疗机构就可以决定最佳的治疗方案。

市场动态:

烧伤的发生率正在上升,车祸及其造成的外伤也越来越多。这些趋势正在推动市场扩张。然而,该市场扩张的主要障碍是生物伤口护理治疗的高价格和皮肤替代品失败的危险。儘管如此,由于糖尿病溃疡的早期治疗可以预防感染、住院和截肢等严重併发症,因此对伤口护理生物产品的需求预计将急剧上升。此外,市售的皮肤替代品提供了伤口癒合功效的临床和科学证据,进一步推动了市场的发展。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具还对全球伤口护理生物製剂市场的每个细分市场进行了包容性评估。伤口护理生物製品产业的成长和趋势为本研究提供了整体方法。

区域分析:

本节涵盖区域前景,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲伤口护理生物製品市场当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。伤口护理生物製剂市场的主要参与者包括 Smith & Nephew plc(英国)、Organogenesis Inc.(美国)、MIMEDX(美国)、Integra LifeSciences(美国)和 Stryker Corporation(美国)。本节包含竞争格局的整体视图,包括各种策略发展,例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章:前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章:执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章:伤口护理生物製品 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按产品分類的市场吸引力分析
    • 按伤口类型分類的市场吸引力分析
    • 最终用户的市场吸引力分析
    • 市场吸引力分析:按地区

第 4 章:价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章:COVID-19 爆发的影响分析

第 6 章:全球伤口护理生物製品市场分析:依产品

  • 按产品概述
  • 历史和预测数据
  • 按产品分析
  • 生物皮肤替代品(人类捐赠者组织衍生产品、无细胞动物衍生产品、生物合成产品)
  • 外用製剂
  • 其他的

第 7 章:全球伤口护理生物製品市场分析:依伤口类型

  • 按伤口类型概述
  • 历史和预测数据
  • 按伤口类型分析
  • 溃疡(糖尿病足溃疡、静脉性溃疡、压疮、其他溃疡)
  • 手术和外伤
  • 伯恩斯
  • 其他伤口护理

第 8 章:全球伤口护理生物製品市场销售分析:按最终用户分类

  • 最终用户概述
  • 历史和预测数据
  • 最终用户分析
  • 医院
  • 门诊手术中心
  • 烧伤护理中心、伤口诊所和家庭环境

第 9 章:全球伤口护理生物製品市场销售分析:按地理位置

  • 区域展望销售分析
  • 简介 销售分析
  • 北美销售分析
    • 概述、历史和预测销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概述、历史和预测销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概述、历史和预测销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概述、历史和预测销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概述、历史和预测销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 10 章:伤口护理生物製品公司的竞争格局

  • 伤口护理生物製品市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 11 章:公司简介

  • 十大公司股票分析
  • 市场集中度
  • Smith & Nephew plc (UK)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Organogenesis Inc. (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • MIMEDX (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Integra LifeSciences (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Stryker Corporation (US)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

注意 - 在公司概况中,财务详细资讯和近期发展视情况而定,或者如果是私人公司,则可能不包括在内

Product Code: VMR11218730

The global demand for Wound Care Biologics Market is presumed to reach the market size of nearly USD 4.06 MN by 2030 from USD 2.63 MN in 2022 with a CAGR of 6.4% under the study period 2023 - 2030.

Wound care biologics are bioengineered products used to treat non-healing lower extremity wounds. Every stage of wound management is covered under wound biologics. This includes determining the wound type, specifying elements that affect wound healing, and applying the appropriate wound management therapy. Wound biologics cover each step of wound care. This entails identifying the type of wound, pinpointing factors that influence wound healing, and implementing the appropriate wound management therapy. Once the wound has been evaluated, and all requirements have been examined, the treatment facility can decide on the best treatment options.

MARKET DYNAMICS:

The prevalence of burn injuries is rising, and there are more car accidents and the traumatic injuries they cause. These trends are driving the market expansion. The main barriers to the expansion of this market, however, are the high price of biologic wound care treatments and the danger of skin substitute failure. Nonetheless, as early treatment of diabetic ulcers can prevent serious complications like infection, hospitalisation, and amputation, demand for wound care biologic products is anticipated to rise dramatically. Furthermore, the commercially available skin substitutes offer clinical and scientific proof of efficacy in wound healing, further propelling the market forward.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of wound care biologics. The growth and trends of wound care biologics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the wound care biologics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Biological Skin Substitutes (Human Donor Tissue-Derived Products, Acellular Animal-Derived Products, Biosynthetic Products)
  • Topical Agents
  • Others

By Wound Type

  • Ulcers(Diabetic Foot Ulcers, Venous Ulcers, Pressure Ulcers, Other Ulcers)
  • Surgical & Traumatic Wounds
  • Burns
  • Others Wound Type

By End User

  • Hospitals
  • Ambulatory Surgery Centers
  • Burn Care Centers & Wound Clinics and Home Settings

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Wound Care Biologics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the wound care biologics market include Smith & Nephew plc (UK), Organogenesis Inc. (US), MIMEDX (US), Integra LifeSciences (US), and Stryker Corporation (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . WOUND CARE BIOLOGICS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Wound Type
    • 3.7.3 Market Attractiveness Analysis By End User
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL WOUND CARE BIOLOGICS MARKET ANALYSIS BY PRODUCT

  • 6.1 Overview by Product
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product
  • 6.4 Biological Skin Substitutes (Human Donor Tissue-derived Products, Acellular Animal-derived Products, Biosynthetic Products) Historic and Forecast Sales by Regions
  • 6.5 Topical Agents Historic and Forecast Sales by Regions
  • 6.6 Others Historic and Forecast Sales by Regions

7 . GLOBAL WOUND CARE BIOLOGICS MARKET ANALYSIS BY WOUND TYPE

  • 7.1 Overview by Wound Type
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Wound Type
  • 7.4 Ulcers(Diabetic Foot Ulcers, Venous Ulcers, Pressure Ulcers, Other Ulcers) Historic and Forecast Sales by Regions
  • 7.5 Surgical & Traumatic Wounds Historic and Forecast Sales by Regions
  • 7.6 Burns Historic and Forecast Sales by Regions
  • 7.7 Other Wound Care Historic and Forecast Sales by Regions

8 . GLOBAL WOUND CARE BIOLOGICS MARKET SALES ANALYSIS BY END USER

  • 8.1 Overview by End User
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End User
  • 8.4 Hospitals Historic and Forecast Sales by Regions
  • 8.5 Ambulatory Surgery Centers Historic and Forecast Sales by Regions
  • 8.6 Burn Care Centers & Wound Clinics and Home Settings Historic and Forecast Sales by Regions

9 . GLOBAL WOUND CARE BIOLOGICS MARKET SALES ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook Sales Analysis
  • 9.2. Introduction Sales Analysis
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE WOUND CARE BIOLOGICS COMPANIES

  • 10.1. Wound Care Biologics Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF WOUND CARE BIOLOGICS INDUSTRY

  • 11.1. Top 10 Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Smith & Nephew plc (UK)
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Organogenesis Inc. (US)
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. MIMEDX (US)
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Integra LifeSciences (US)
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Stryker Corporation (US)
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product (USD MN)
  • Biological Skin Substitutes (Human Donor Tissue-derived Products, Acellular Animal-derived Products, Biosynthetic Products) Market Sales by Geography (USD MN)
  • Topical Agents Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by Wound Type (USD MN)
  • Ulcers(Diabetic Foot Ulcers, Venous Ulcers, Pressure Ulcers, Other Ulcers) Market Sales by Geography (USD MN)
  • Surgical & Traumatic Wounds Market Sales by Geography (USD MN)
  • Burns Market Sales by Geography (USD MN)
  • Others Wound Type Market Sales by Geography (USD MN)
  • Analysis by End User (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Ambulatory Surgery Centers Market Sales by Geography (USD MN)
  • Burn Care Centers & Wound Clinics and Home Settings Market Sales by Geography (USD MN)
  • Global Wound Care Biologics Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Wound Care Biologics Report
  • Market Research Process
  • Market Research Methodology
  • Global Wound Care Biologics Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product
  • Market Attractiveness Analysis by Wound Type
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product (USD MN)
  • Biological Skin Substitutes (Human Donor Tissue-derived Products, Acellular Animal-derived Products, Biosynthetic Products) Market Sales by Geography (USD MN)
  • Topical Agents Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Wound Type (USD MN)
  • Ulcers(Diabetic Foot Ulcers, Venous Ulcers, Pressure Ulcers, Other Ulcers) Market Sales by Geography (USD MN)
  • Surgical & Traumatic Wounds Market Sales by Geography (USD MN)
  • Burns Market Sales by Geography (USD MN)
  • Others Wound Type Market Sales by Geography (USD MN)
  • Global Market Analysis by End User (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Ambulatory Surgery Centers Market Sales by Geography (USD MN)
  • Burn Care Centers & Wound Clinics and Home Settings Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.